Ascendancy of unfolded protein response over glioblastoma: estimating progression, prognosis and survival

References

• Adamski, V., Hattermann, K., Kubelt, C., Cohrs, G., Lucius, R., Synowitz, M., Sebens, S., & Held-Feindt, J. (2020). Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1. Oncogene, 39(22), 4421–4435. https://doi.org/10.1038/s41388-020-1302-8
   PubMedGoogle Scholar
• Al-Rawashdeh, F. Y., Scriven, P., Cameron, I. C., Vergani, P. V., & Wyld, L. (2010). Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology, 22(9), 1099–1105. https://doi.org/10.1097/MEG.0b013e3283378405
   PubMedGoogle Scholar
• Alafate, W., Xu, D., Wu, W., Xiang, J., Ma, X., Xie, W., Bai, X., Wang, M., & Wang, J. (2020). Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling. Journal of Experimental & Clinical Cancer Research, 39(1), 239. https://doi.org/10.1186/s13046-020-01750-4
   PubMedGoogle Scholar
• Albulescu, R., Codrici, E., Popescu, I. D., Mihai, S., Necula, L. G., Petrescu, D., Teodoru, M., & Tanase, C. P. (2013). Cytokine patterns in brain tumour progression. Mediators of Inflammation, 2013, 979748. https://doi.org/10.1155/2013/979748
   PubMed Web of Science ®Google Scholar
• Ancrile, B., Lim, K. H., & Counter, C. M. (2007). Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes & Development, 21(14), 1714–1719. https://doi.org/10.1101/gad.1549407
   PubMed Web of Science ®Google Scholar
• Arima, Y., Shiraishi, H., Saito, A., Yoshimoto, K., Namera, A., Makita, R., Murata, K., Imaizumi, K., & Nagao, M. (2016). The sarin-like organophosphorus agent bis(isopropyl methyl)phosphonate induces ER stress in human astrocytoma cells. The Journal of Toxicological Sciences, 41(5), 617–625. https://doi.org/10.2131/jts.41.617
   PubMedGoogle Scholar
• Bartholin, L., Guindon, S., Martel, S., Corbo, L., & Rimokh, R. (2007). Identification of NF-kappaB responsive elements in follistatin related gene (FLRG) promoter. Gene, 393(1–2), 153–162. https://doi.org/10.1016/j.gene.2007.02.007
   PubMed Web of Science ®Google Scholar
• Bastin, G., Dissanayake, K., Langburt, D., Tam, A. L. C., Lee, S. H., Lachhar, K., & Heximer, S. P. (2020). RGS4 controls Gαi3-mediated regulation of Bcl-2 phosphorylation on TGN38-containing intracellular membranes. Journal of Cell Science, 133(12). https://doi.org/10.1242/jcs.241034
   Google Scholar
• Benetatos, L., Dasoula, A., Hatzimichael, E., Syed, N., Voukelatou, M., Dranitsaris, G., Bourantas, K. L., & Crook, T. (2011). Polo-Like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: Genetic and epigenetic interactions. Annals of Hematology, 90(9), 1037–1045. https://doi.org/10.1007/s00277-011-1193-4
   PubMed Web of Science ®Google Scholar
• Bobrovnikova-Marjon, E., Grigoriadou, C., Pytel, D., Zhang, F., Ye, J., Koumenis, C., Cavener, D., & Diehl, J. A. (2010). PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene, 29(27), 3881–3895. https://doi.org/10.1038/onc.2010.153
   PubMedGoogle Scholar
• Buruiana, A., Florian, S. I., Florian, A. I., Timis, T. L., Mihu, C. M., Miclaus, M., Osan, S., Hrapsa, I., Cataniciu, R. C., Farcas, M., & Susman, S. (2020). The roles of miRNA in Glioblastoma tumor Cell communication: Diplomatic and aggressive negotiations. International Journal of Molecular Sciences, 21(6), 1950. https://doi.org/10.3390/ijms21061950
   PubMed Web of Science ®Google Scholar
• Cerezo, M., & Rocchi, S. (2017). New anti-cancer molecules targeting HSPA5/BIP to induce endoplasmic reticulum stress, autophagy and apoptosis. Autophagy, 13(1), 216–217. https://doi.org/10.1080/15548627.2016.1246107
   PubMed Web of Science ®Google Scholar
• Chen, J., & Tang, J., Chen, W., Gao, Y., He, Y., Zhang, Q., Ran, Q., Cao, F. & Yao, S. (2017). Effects of syndecan-1 on the expression of syntenin and the migration of U251 glioma cells. Oncology Letters, 14(6), 7217–7224. https://doi.org/10.3892/ol.2017.7170
   PubMedGoogle Scholar
• Chen, Y., Mi, Y., Zhang, X., Ma, Q., Song, Y., Zhang, L., Wang, D., Xing, J., Hou, B., Li, H., Jin, H., Du, W., & Zou, Z. (2019). Dihydroartemisinin-Induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells. Journal of Experimental & Clinical Cancer Research, 38(1), 402. https://doi.org/10.1186/s13046-019-1413-7
   PubMed Web of Science ®Google Scholar
• Chen, Z., Mou, L., Pan, Y., Feng, C., Zhang, J., & Li, J. (2019). CXCL8 Promotes Glioma progression by activating the JAK/STAT1/HIF-1α/Snail signaling axis. OncoTargets and Therapy, 12, 8125–8138. https://doi.org/10.2147/ott.S224721
   PubMed Web of Science ®Google Scholar
• Dadey, D. Y., Kapoor, V., Khudanyan, A., Urano, F., Kim, A. H., Thotala, D., & Hallahan, D. E. (2016). The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma. Oncotarget, 7(2), 2080–2092. https://doi.org/10.18632/oncotarget.6712
   PubMedGoogle Scholar
• Dai, L., Huang, C., Chen, L., Shan, G., & Li, Z. (2015). Altered expression of microRnas in the response to ER stress. Science Bulletin, 60(2), 202–209. https://doi.org/10.1007/s11434-014-0657-z
   Google Scholar
• De Boeck, A., Ahn, B. Y., D’Mello, C., Lun, X., Menon, S. V., Alshehri, M. M., Szulzewsky, F., Shen, Y., Khan, L., Dang, N. H., Reichardt, E., Goring, K. A., King, J., Grisdale, C. J., Grinshtein, N., Hambardzumyan, D., Reilly, K. M., Blough, M. D., Cairncross, J. G., … Reichardt E. (2020). Glioma-Derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression. Nature Communications, 11(1), 4997. https://doi.org/10.1038/s41467-020-18569-4
   PubMedGoogle Scholar
• de la Iglesia, N., Konopka, G., Lim, K.-L., Nutt, C. L., Bromberg, J. F., Frank, D. A., Mischel, P. S., Louis, D. N., & Bonni, A. (2008). Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. Journal of Neuroscience, 28(23), 5870–5878. https://doi.org/10.1523/JNEUROSCI.5385-07.2008
   PubMedGoogle Scholar
• Desbaillets, I., Diserens, A. C., Tribolet, N., Hamou, M. F., & Van Meir, E. G. (1997). Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. The Journal of Experimental Medicine, 186(8), 1201–1212. https://doi.org/10.1084/jem.186.8.1201
   PubMed Web of Science ®Google Scholar
• Du, J., Yan, X., Mi, S., Li, Y., Ji, H., Hou, K., Ma, S., Ba, Y., Zhou, P., Chen, L., Xie, R., & Hu, S. (2020). Identification of prognostic model and biomarkers for cancer stem cell characteristics in Glioblastoma by network analysis of multi-omics data and stemness indices. Frontiers in Cell and Developmental Biology, 8, 558961. https://doi.org/10.3389/fcell.2020.558961
   PubMedGoogle Scholar
• Gao, X., Wang, X., He, H., & Cao, Y. (2021). LINC02308 promotes the progression of glioma through activating mTOR/AKT-signaling pathway by targeting miR-30e-3p/tm4sf1 axis. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-021-09604-1
   Google Scholar
• Gimenez, M., Marie, S. K., Oba-Shinjo, S., Uno, M., Izumi, C., Oliveira, J. B., & Rosa, J. C. (2015). Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma. BMC Cancer BMC Cancer, 15(1), 481. https://doi.org/10.1186/s12885-015-1473-9
   PubMedGoogle Scholar
• Graner, M. W. (2015). The unfolded protein response in glioblastomas: Targetable or trouble? Future Science OA, 1(2), FSO45. https://doi.org/10.4155/fso.15.45
   PubMedGoogle Scholar
• Guda, M. R., Velpula, K. K., Asuthkar, S., Cain, C. P., & Tsung, A. J. (2020). Targeting RGS4 ablates Glioblastoma proliferation. International Journal of Molecular Sciences, 21(9), 3300. https://doi.org/10.3390/ijms21093300
   PubMedGoogle Scholar
• Gundamaraju, R., Vemuri, R., Chong, W. C., Myers, S., Norouzi, S., Shastri, M. D., & Eri, R. (2018). Interplay between endoplasmic reticular stress and survivin in colonic epithelial cells. Cells, 7(10), 171. https://doi.org/10.3390/cells7100171
   PubMedGoogle Scholar
• Gundamaraju, R., Vemuri, R., Chong, W. C., Bulmer, A. C., & Eri, R. (2019). Bilirubin attenuates ER stress-mediated inflammation, escalates apoptosis and reduces proliferation in the LS174T colonic epithelial cell line. International Journal of Medical Sciences, 16(1), 135–144. https://doi.org/10.7150/ijms.29134
   PubMedGoogle Scholar
• Guo, X. R., Wu, M. Y., Dai, L. J., Huang, Y., Shan, M. Y., Ma, S. N., Wang, J., Peng, H., Ding, Y., Zhang, Q. F., Tang, J. M., Ruan, X. Z., & Li, D. S. (2019). Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma. Journal of Experimental & Clinical Cancer Research, 38(1), 394. https://doi.org/10.1186/s13046-019-1393-7
   PubMedGoogle Scholar
• Harding, H. P., Zhang, Y., Zeng, H., Novoa, I., Lu, P. D., Calfon, M., Sadri, N., Yun, C., Popko, B., Paules, R., Stojdl, D. F., Bell, J. C., Hettmann, T., Leiden, J. M., & Ron, D. (2003). An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Molecular Cell, 11(3), 619–633. https://doi.org/10.1016/s1097-2765(03)00105-9
   PubMed Web of Science ®Google Scholar
• He, G. L., Luo, Z., Shen, T. T., Yang, J., Li, P., Luo, X., & Yang, X. S. (2019). Inhibition of HSP90β by ganetespib blocks the microglial signalling of evoked pro-inflammatory responses to heat shock. The International Journal of Biochemistry & Cell Biology, 106, 35–45. https://doi.org/10.1016/j.biocel.2018.11.003
   PubMedGoogle Scholar
• Huang, S. P., Chan, Y. C., Huang, S. Y., & Lin, Y. F. (2019). Overexpression of PSAT1 gene is a favorable prognostic marker in lower-grade Gliomas and predicts a favorable outcome in patients with IDH1 mutations and chromosome 1p19q codeletion. Cancers (Basel), 12(1), 13. https://doi.org/10.3390/cancers12010013
   PubMed Web of Science ®Google Scholar
• Huang, J., Pan, H., Wang, J., Wang, T., Huo, X., Ma, Y., Lu, Z., Sun, B., & Jiang, H. (2021). Unfolded protein response in colorectal cancer. Cell & Bioscience, 11(1), 26. https://doi.org/10.1186/s13578-021-00538-z
   PubMedGoogle Scholar
• Huettner, C., Paulus, W., & Roggendorf, W. (1994). Increased amounts of IL-10 mRNA in anaplastic astrocytomas and glioblastoma multiforme. Verhandlungen der Deutschen Gesellschaft Fur Pathologie, 78, 418–422.
   PubMedGoogle Scholar
• Hyoda, T., Tsujioka, T., Nakahara, T., Suemori, S., Okamoto, S., Kataoka, M., & Tohyama, K. (2015). Rigosertib induces cell death of a myelodysplastic syndrome-derived cell line by DNA damage-induced G2/M arrest. Cancer Science, 106(3), 287–293. https://doi.org/10.1111/cas.12605
   PubMed Web of Science ®Google Scholar
• Ikemoto, K., Matsumoto, T., Ohtsuki, M., Itoh, M., Tada, S., Udagawa, Y., Sumi-Ichinose, C., Kondo, K., & Nomura, T. (2008). 2,4-Diamino-6-Hydroxypyrimidine (DAHP) suppresses cytokine-induced VCAM-1 expression on the cell surface of human umbilical vein endothelial cells in a BH(4)-independent manner. Biochimica Et Biophysica Acta, 1780(7–8), 960–965. https://doi.org/10.1016/j.bbagen.2008.03.012
   PubMedGoogle Scholar
• Jeon, Y. J., Kim, T., Park, D., Nuovo, G. J., Rhee, S., Joshi, P., Lee, B. K., Jeong, J., Suh, S. S., Grotzke, J. E., & Kim, S. H. (2018). miRNA-Mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC. Nature Communications, 9(1), 1–13. https://doi.org/10.1038/s41467-018-07561-8
   PubMedGoogle Scholar
• Jiang, J., Zhang, L., Chen, H., Lei, Y., Zhang, T., Wang, Y., Jin, P., Lan, J., Zhou, L., Huang, Z., & Li, B. (2020). Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma. Autophagy, 16(1), 106–122. https://doi.org/10.1080/15548627.2019.1598752
   PubMed Web of Science ®Google Scholar
• Jin, X., Nie, E., Zhou, X., Zeng, A., Yu, T., Zhi, T., Jiang, K., Wang, Y., Zhang, J., & You, Y. (2017). Fstl1 promotes Glioma growth through the BMP4/Smad1/5/8 signaling pathway. Cellular Physiology and Biochemistry, 44(4), 1616–1628. https://doi.org/10.1159/000485759
   PubMedGoogle Scholar
• Kolinsky, M. A., & Gross, S. S. (2004). The mechanism of potent GTP cyclohydrolase I inhibition by 2,4-diamino-6-hydroxypyrimidine: Requirement of the GTP cyclohydrolase I feedback regulatory protein. The Journal of Biological Chemistry, 279(39), 40677–40682. https://doi.org/10.1074/jbc.M405370200
   PubMedGoogle Scholar
• Krex, D., Klink, B., Hartmann, C., von Deimling, A., Pietsch, T., Simon, M., Sabel, M., Steinbach, J. P., Heese, O., Reifenberger, G., Weller, M., Schackert, G., & German Glioma, N. (2007). Long-Term survival with glioblastoma multiforme. Brain, 130(Pt 10), 2596–2606. https://doi.org/10.1093/brain/awm204
   PubMedGoogle Scholar
• Le Mercier, M., Mathieu, V., Haibe-Kains, B., Bontempi, G., Mijatovic, T., Decaestecker, C., Kiss, R., & Lefranc, F. (2008). Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. Journal of Neuropathology & Experimental Neurology, 67(5), 456–469. https://doi.org/10.1097/NEN.0b013e318170f892
   PubMedGoogle Scholar
• Lee, E., Nichols, P., Spicer, D., Groshen, S., Yu, M. C., & Lee, A. S. (2006). GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Cancer Research, 66(16), 7849–7853. https://doi.org/10.1158/0008-5472.Can-06-1660
   PubMed Web of Science ®Google Scholar
• Li, R., Li, G., Deng, L., Liu, Q., Dai, J., Shen, J., & Zhang, J. (2010). IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1. Oncology Reports, 23(6), 1553–1559. https://doi.org/10.3892/or_00000795
   PubMed Web of Science ®Google Scholar
• Li, X. X., Zhang, H. S., Xu, Y. M., Zhang, R. J., Chen, Y., Fan, L., Qin, Y. Q., Liu, Y., Li, M., & Fang, J. (2017). Knockdown of IRE1α inhibits colonic tumorigenesis through decreasing β-catenin and IRE1α targeting suppresses colon cancer cells. Oncogene, 36(48), 6738–6746. https://doi.org/10.1038/onc.2017.284
   PubMedGoogle Scholar
• Li, Y., He, Z. C., Zhang, X. N., Liu, Q., Chen, C., Zhu, Z., Chen, Q., Shi, Y., Yao, X. H., Cui, Y. H., Zhang, X., Wang, Y., Kung, H. F., Ping, Y. F., & Bian, X. W. (2018). Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1. Cancer Letters, 416, 66–74. https://doi.org/10.1016/j.canlet.2017.11.033
   PubMedGoogle Scholar
• Liu, Y., Ji, W., Shergalis, A., Xu, J., Delaney, A. M., Calcaterra, A., Pal, A., Ljungman, M., Neamati, N., & Rehemtulla, A. (2019). Activation of the unfolded protein response via inhibition of protein disulfide isomerase decreases the capacity for DNA repair to sensitize Glioblastoma to radiotherapy. Cancer Research, 79(11), 2923–2932. https://doi.org/10.1158/0008-5472.Can-18-2540
   PubMedGoogle Scholar
• Liu, K., Tsung, K., & Attenello, F. J. (2020). Characterizing cell stress and GRP78 in Glioma to enhance tumor treatment. Frontiers in Oncology, 10, 608911. https://doi.org/10.3389/fonc.2020.608911
   PubMedGoogle Scholar
• Logue, S. E., McGrath, E. P., Cleary, P., Greene, S., Mnich, K., Almanza, A., Chevet, E., Dwyer, R. M., Oommen, A., Legembre, P., Godey, F., Madden, E. C., Leuzzi, B., Obacz, J., Zeng, Q., Patterson, J. B., Jager, R., Gorman, A. M., & Samali, A. (2018). Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nature Communications, 9(1), 3267. https://doi.org/10.1038/s41467-018-05763-8
   PubMedGoogle Scholar
• Luo, X., Yao, J., Nie, P., Yang, Z., Feng, H., Chen, P., Shi, X., & Zou, Z. (2016). FOXM1 promotes invasion and migration of colorectal cancer cells partially dependent on HSPA5 transactivation. Oncotarget, 7(18), 26480–26495. https://doi.org/10.18632/oncotarget.8419
   PubMedGoogle Scholar
• Luo, X., Xu, S., Zhong, Y., Tu, T., Xu, Y., Li, X., Wang, B., & Yang, F. (2019). High gene expression levels of VEGFA and CXCL8 in the peritumoral brain zone are associated with the recurrence of glioblastoma: A bioinformatics analysis. Oncology Letters, 18(6), 6171–6179. https://doi.org/10.3892/ol.2019.10988
   PubMedGoogle Scholar
• Malhi, H. (2014). Micrornas in ER STRESS: DIVERGENT ROLES in CELL FATE DECISIONS. Current Pathobiology Reports, 2(3), 117–122. https://doi.org/10.1007/s40139-014-0046-y
   PubMedGoogle Scholar
• Marciniak, S. J., Yun, C. Y., Oyadomari, S., Novoa, I., Zhang, Y., Jungreis, R., Nagata, K., Harding, H. P., & Ron, D. (2004). CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes & Development, 18(24), 3066–3077. https://doi.org/10.1101/gad.1250704
   PubMed Web of Science ®Google Scholar
• Moller, H. G., Rasmussen, A. P., Andersen, H. H., Johnsen, K. B., Henriksen, M., & Duroux, M. (2013). A systematic review of microRNA in glioblastoma multiforme: Micro-modulators in the mesenchymal mode of migration and invasion. Molecular Neurobiology, 47(1), 131–144. https://doi.org/10.1007/s12035-012-8349-7
   PubMed Web of Science ®Google Scholar
• Murat, A., Migliavacca, E., Hussain, S. F., Heimberger, A. B., Desbaillets, I., Hamou, M. F., Ruegg, C., Stupp, R., Delorenzi, M., & Hegi, M. E. (2009). Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia. PLoS One, 4(6), e5947. https://doi.org/10.1371/journal.pone.0005947
   PubMed Web of Science ®Google Scholar
• Pan, Y., Zhang, J. H., Zhao, L., Guo, J. C., Wang, S., Zhao, Y., Tao, S., Wang, H., & Zhu, Y. B. (2020). A robust two-gene signature for glioblastoma survival prediction. Journal of Cellular Biochemistry, 121(7), 3593–3605. https://doi.org/10.1002/jcb.29653
   PubMedGoogle Scholar
• Panagiotou, G., Papakonstantinou, E., Vagionas, A., Polyzos, S. A., & Mantzoros, C. S. (2019). Serum levels of activins, follistatins, and growth factors in neoplasms of the breast: A case-control study. The Journal of Clinical Endocrinology & Metabolism, 104(2), 349–358. https://doi.org/10.1210/jc.2018-01581
   PubMedGoogle Scholar
• Peñaranda Fajardo, N. M., Meijer, C., & Kruyt, F. A. (2016). The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma. Biochemical Pharmacology, 118, 1–8. https://doi.org/10.1016/j.bcp.2016.04.008
   PubMed Web of Science ®Google Scholar
• Peñaranda-Fajardo, N. M., Meijer, C., Liang, Y., Dijkstra, B. M., Aguirre-Gamboa, R., den Dunnen, W. F. A., & Kruyt, F. A. E. (2019). ER stress and UPR activation in glioblastoma: Identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation. Cell Death & Disease, 10(10), 690. https://doi.org/10.1038/s41419-019-1934-1
   PubMedGoogle Scholar
• Pistollato, F., Abbadi, S., Rampazzo, E., Persano, L., Della Puppa, A., Frasson, C., Sarto, E., Scienza, R., D’Avella, D., & Basso, G. (2010). Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells, 28(5), 851–862. https://doi.org/10.1002/stem.415
   PubMed Web of Science ®Google Scholar
• Qiu, B., Zhang, D., Wang, C., Tao, J., Tie, X., Qiao, Y., Xu, K., Wang, Y., & Wu, A. (2011). IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas. Molecular Biology Reports, 38(5), 3585–3591. https://doi.org/10.1007/s11033-010-0469-4
   PubMed Web of Science ®Google Scholar
• Rapraeger, A. C. (2013). Synstatin: A selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis. The FEBS Journal, 280(10), 2207–2215. https://doi.org/10.1111/febs.12160
   PubMed Web of Science ®Google Scholar
• Reddy, M. V., Akula, B., Jatiani, S., Vasquez-Del Carpio, R., Billa, V. K., Mallireddigari, M. R., Cosenza, S. C., Venkata Subbaiah, D. R., Bharathi, E. V., Pallela, V. R., Ramkumar, P., Jain, R., Aggarwal, A. K., & Reddy, E. P. (2016). Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2). Bioorganic & Medicinal Chemistry, 24(4), 521–544. https://doi.org/10.1016/j.bmc.2015.11.045
   PubMedGoogle Scholar
• Rolhion, C., Penault-Llorca, F., Kémény, J. L., Lemaire, J. J., Jullien, C., Labit-Bouvier, C., Finat Duclos, F., & Verrelle, P. (2001). Interleukin-6 overexpression as a marker of malignancy in human gliomas. Journal of Neurosurgery, 94(1), 97–101. https://doi.org/10.3171/jns.2001.94.1.0097
   PubMedGoogle Scholar
• Rouschop, K. M., van den Beucken, T., Dubois, L., Niessen, H., Bussink, J., Savelkouls, K., Keulers, T., Mujcic, H., Landuyt, W., Voncken, J. W., Lambin, P., van der Kogel, A. J., Koritzinsky, M., & Wouters, B. G. (2010). The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. The Journal of Clinical Investigation, 120(1), 127–141. https://doi.org/10.1172/jci40027
   PubMed Web of Science ®Google Scholar
• Ryu, J., Ku, B. M., Lee, Y. K., Jeong, J. Y., Kang, S., Choi, J., Yang, Y., Lee, D. H., Roh, G. S., Kim, H. J., Cho, G. J., Choi, W. S., Kim, N., & Kang, S. S. (2011). Resveratrol reduces TNF-α-induced U373MG human glioma cell invasion through regulating NF-κB activation and uPa/upar expression. Anticancer Research, 31(12), 4223–4230.
   PubMed Web of Science ®Google Scholar
• Scriven, P., Coulson, S., Haines, R., Balasubramanian, S., Cross, S., & Wyld, L. (2009). Activation and clinical significance of the unfolded protein response in breast cancer. British Journal of Cancer, 101(10), 1692–1698. https://doi.org/10.1038/sj.bjc.6605365
   PubMed Web of Science ®Google Scholar
• Seol, J. H., Song, T. Y., Oh, S. E., Jo, C., Choi, A., Kim, B., Park, J., Hong, S., Song, I., Jung, K. Y., Yang, J. H., Park, H., Ahn, J. H., Han, J. W., & Cho, E. J. (2015). Identification of small molecules that inhibit the histone chaperone Asf1 and its chromatin function. BMB Reports, 48(12), 685–690. https://doi.org/10.5483/bmbrep.2015.48.12.063
   PubMedGoogle Scholar
• Sharma, I., Singh, A., Siraj, F., & Saxena, S. (2018). IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma. Journal of Biomedical Science, 25(1), 62. https://doi.org/10.1186/s12929-018-0464-y
   PubMedGoogle Scholar
• Shen, T., Li, Y., Chen, Z., Liang, S., Guo, Z., Wang, P., Wu, Q., Ba, G., & Fu, Q. (2017). CHOP negatively regulates Polo-like kinase 2 expression via recruiting C/EBPα to the upstream-promoter in human osteosarcoma cell line during ER stress. The International Journal of Biochemistry & Cell Biology, 89, 207–215. https://doi.org/10.1016/j.biocel.2017.06.012
   PubMedGoogle Scholar
• Sheng, X., Arnoldussen, Y. J., Storm, M., Tesikova, M., Nenseth, H. Z., Zhao, S., Fazli, L., Rennie, P., Risberg, B., Waehre, H., Danielsen, H., Mills, I. G., Jin, Y., Hotamisligil, G., & Saatcioglu, F. (2015). Divergent androgen regulation of unfolded protein response pathways drives prostate cancer. EMBO Molecular Medicine, 7(6), 788–801. https://doi.org/10.15252/emmm.201404509
   PubMedGoogle Scholar
• Shi, S., Zhong, D., Xiao, Y., Wang, B., Wang, W., Zhang, F., & Huang, H. (2017). Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/fak-associated signaling pathway. Oncotarget, 8(25), 40922–40934. https://doi.org/10.18632/oncotarget.16733
   PubMedGoogle Scholar
• Song, L., & Jope, R. S. (2006). Cellular stress increases RGS2 mRNA and decreases RGS4 mRNA levels in SH-SY5Y cells. Neuroscience Letters, 402(3), 205–209. https://doi.org/10.1016/j.neulet.2006.03.023
   PubMedGoogle Scholar
• Stupp, R., Reni, M., Gatta, G., Mazza, E., & Vecht, C. (2007). Anaplastic astrocytoma in adults. Critical Reviews in Oncology/hematology, 63(1), 72–80. https://doi.org/10.1016/j.critrevonc.2007.03.003
   PubMedGoogle Scholar
• Su, J., Guo, B., Zhang, T., Wang, K., Li, X., & Liang, G. (2015). Stanniocalcin-1, a new biomarker of glioma progression, is associated with prognosis of patients. Tumor Biology, 36(8), 6333–6339. https://doi.org/10.1007/s13277-015-3319-0
   PubMedGoogle Scholar
• Symons, K. T., Massari, M. E., Dozier, S. J., Nguyen, P. M., Jenkins, D., Herbert, M., Gahman, T. C., Noble, S. A., Rozenkrants, N., Zhang, Y., Rao, T. S., Shiau, A. K., & Hassig, C. A. (2008). Inhibition of inducible nitric oxide synthase expression by a novel small molecule activator of the unfolded protein response. Current Chemical Genomics, 2, 1–9. https://doi.org/10.2174/1875397300802010001
   PubMedGoogle Scholar
• Tchirkov, A., Rolhion, C., Bertrand, S., Dore, J.-F., Dubost, J.-J., & Verrelle, P. (2001). IL-6 gene amplification and expression in human glioblastomas. British Journal of Cancer, 85(4), 518–522. https://doi.org/10.1054/bjoc.2001.1942
   PubMedGoogle Scholar
• Tran, A. N., Walker, K., Harrison, D. G., Chen, W., Mobley, J., Hocevar, L., Hackney, J. R., Sedaka, R. S., Pollock, J. S., Goldberg, M. S., Hambardzumyan, D., Cooper, S. J., Gillespie, Y., & Hjelmeland, A. B. (2018). Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance. Neuro-Oncology, 20(8), 1055–1067. https://doi.org/10.1093/neuonc/noy012
   PubMedGoogle Scholar
• Uckun, F. M., Qazi, S., Ozer, Z., Garner, A. L., Pitt, J., Ma, H., & Janda, K. D. (2011). Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network. British Journal of Haematology, 153(6), 741–752. https://doi.org/10.1111/j.1365-2141.2011.08671.x
   PubMedGoogle Scholar
• Ventero, M. P., Fuentes-Baile, M., Quereda, C., Perez-Valeciano, E., Alenda, C., Garcia-Morales, P., Esposito, D., Dorado, P., Manuel Barbera, V., & Saceda, M. (2019). Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3. PLoS One, 14(2), e0212581. https://doi.org/10.1371/journal.pone.0212581
   PubMedGoogle Scholar
• Villa, P., Triulzi, S., Cavalieri, B., DiBitondo, R., Bertini, R., Barbera, S., Bigini, P., Mennini, T., Gelosa, P., Tremoli, E., Sironi, L., & Ghezzi, P. (2007). The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats. Molecular Medicine, 13(3–4), 125–133. https://doi.org/10.2119/2007-00008.Villa
   PubMedGoogle Scholar
• Visintin, A., Knowlton, K., Tyminski, E., Lin, C. I., Zheng, X., Marquette, K., Jain, S., Tchistiakova, L., Li, D., O’Donnell, C. J., & Maderna, A. (2015). Novel anti-TM4SF1 antibody–drug conjugates with activity against tumor cells and tumor vasculature. Molecular Cancer Therapeutics, 14(8), 1868–1876. https://doi.org/10.1158/1535-7163.MCT-15-0188
   PubMedGoogle Scholar
• Wang, Y., Ning, Y., Alam, G. N., Jankowski, B. M., Dong, Z., Nör, J. E., & Polverini, P. J. (2013). Amino acid deprivation promotes tumor angiogenesis through the GCN2/ATF4 pathway. Neoplasia, 15(8), 989–997. https://doi.org/10.1593/neo.13262
   PubMed Web of Science ®Google Scholar
• Wang, J., Lee, J., Liem, D., & Ping, P. (2017). HSPA5 Gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum. Gene, 618, 14–23. https://doi.org/10.1016/j.gene.2017.03.005
   PubMedGoogle Scholar
• Wang, Z., Tang, W., Yuan, J., Qiang, B., Han, W., & Peng, X. (2020). Integrated analysis of RNA-binding proteins in Glioma. Cancers (Basel), 12(4): 892. https://doi.org/10.3390/cancers12040892
   PubMedGoogle Scholar
• Weiler, M., Pfenning, P. N., Thiepold, A. L., Blaes, J., Jestaedt, L., Gronych, J., Dittmann, L. M., Berger, B., Jugold, M., Kosch, M., Combs, S. E., von Deimling, A., Weller, M., Bendszus, M., Platten, M., & Wick, W. (2013). Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment. Oncogene, 32(9), 1099–1109. https://doi.org/10.1038/onc.2012.137
   PubMedGoogle Scholar
• Xia, X., Cao, F., Yuan, X., Zhang, Q., Chen, W., Yu, Y., Xiao, H., Han, C., & Yao, S. (2019). Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme. PeerJ, 7, e7974. https://doi.org/10.7717/peerj.7974
   PubMedGoogle Scholar
• Xiong, Y., & Wang, Q. (2019). STC1 regulates glioblastoma migration and invasion via the TGF‑β/SMAD4 signaling pathway. Molecular Medicine Reports, 20(4), 3055–3064. https://doi.org/10.3892/mmr.2019.10579
   PubMedGoogle Scholar
• Xu, Y., Yuan, J., Zhang, Z., Lin, L., & Xu, S. (2012). Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis. Molecular Biology Reports, 39(9), 8979–8985. https://doi.org/10.1007/s11033-012-1767-9
   PubMedGoogle Scholar
• Xu, H., Liu, P., Yan, Y., Fang, K., Liang, D., Hou, X., Zhang, X., Wu, S., Ma, J., Wang, R., Li, T., Piao, H., & Meng, S. (2020). FKBP9 promotes the malignant behavior of glioblastoma cells and confers resistance to endoplasmic reticulum stress inducers. Journal of Experimental & Clinical Cancer Research, 39(1), 44. https://doi.org/10.1186/s13046-020-1541-0
   PubMedGoogle Scholar
• Yamashita, D., Kondo, T., Ohue, S., Takahashi, H., Ishikawa, M., Matoba, R., Suehiro, S., Kohno, S., Harada, H., Tanaka, J., & Ohnishi, T. (2015). miR340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator. Cancer Research, 75(6), 1123–1133. https://doi.org/10.1158/0008-5472.CAN-14-0938
   PubMedGoogle Scholar
• Yamashita, Y., Morita, S., Hosoi, H., Kobata, H., Kishimoto, S., Ishibashi, T., Mishima, H., Kinoshita, A., Backes, B. J., Yoshiura, K. I., Papa, F. R., Sonoki, T., & Tamura, S. (2020). Targeting adaptive IRE1α signaling and PLK2 in multiple Myeloma: possible anti-tumor mechanisms of KIRA8 and Nilotinib. International Journal of Molecular Sciences, 21(17), 6314. https://doi.org/10.3390/ijms21176314
   PubMedGoogle Scholar
• Yan, Z., Hu, Y., Zhang, Y., Pu, Q., Chu, L., & Liu, J. (2022). Effects of endoplasmic reticulum stress‑mediated CREB3L1 on apoptosis of glioma cells. Molecular and Clinical Oncology, 16(4), 83. https://doi.org/10.3892/mco.2022.2516
   PubMedGoogle Scholar
• Ye, J., Kumanova, M., Hart, L. S., Sloane, K., Zhang, H., De Panis, D. N., Bobrovnikova-Marjon, E., Diehl, J. A., Ron, D., & Koumenis, C. (2010). The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. The EMBO Journal, 29(12), 2082–2096. https://doi.org/10.1038/emboj.2010.81
   PubMed Web of Science ®Google Scholar
• Yeung, Y. T., McDonald, K. L., Grewal, T., & Munoz, L. (2013). Interleukins in glioblastoma pathophysiology: Implications for therapy. British Journal of Pharmacology, 168(3), 591–606. https://doi.org/10.1111/bph.12008
   PubMed Web of Science ®Google Scholar
• Yoon, S. Y., Woo, J., Park, J. O., Choi, E. J., Shin, H. S., Roh, D. H., & Kim, K. S. (2015). Intrathecal RGS4 inhibitor, CCG50014, reduces nociceptive responses and enhances opioid-mediated analgesic effects in the mouse formalin test. Anesthesia & Analgesia, 120(3), 671–677. https://doi.org/10.1213/ANE.0000000000000607
   PubMedGoogle Scholar
• Zhou, H., Miki, R., Eeva, M., Yang, L., Seligson, D., Yoshimura, A., Jamieson, C. A., & Cacalano, N. A. (2006). Aberrant regulation of SOCS1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme. AACR.
   Google Scholar
• Zhou, H., Miki, R., Eeva, M., Fike, F. M., Seligson, D., Yang, L., Yoshimura, A., Teitell, M. A., Jamieson, C. A., & Cacalano, N. A. (2007). Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme. Clinical Cancer Research, 13(8), 2344–2353. https://doi.org/10.1158/1078-0432.Ccr-06-2303
   PubMed Web of Science ®Google Scholar
• Zhu, S., Zhang, Q., Sun, X., Zeh, H. J., 3RD, Lotze, M. T., Kang, R., & Tang, D. (2017). HSPA5 regulates ferroptotic cell death in cancer cells. Cancer Research, 77(8), 2064–2077. https://doi.org/10.1158/0008-5472.CAN-16-1979
   PubMed Web of Science ®Google Scholar